Back to search

Article

Novel Immune-Related Gene Signature for Risk Stratification and Prognosis of Survival in Estrogen Receptor (ER) or Progesterone Receptor (PR) Positive and Human Epidermal Growth Factor Receptor 2 (HER2) Negative Breast Cancer

2021-05-11

Abstract excerpt

<h4>Background: </h4> Although intrinsic molecular subtype has been extensively used, the risk stratification have not been fully elucidated in estrogen receptor (ER) or progesterone receptor (PR) positive and human epidermal growth factor receptor 2 (HER2) negative breast cancer. <h4>Methods: </h4>: RNA transcriptional data from The Cancer Genome Atlas (TCGA), METABRIC and GEO were used. Immune-related genes were...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
28a3d017-3d43-5226-9214-b9f5f3d29165
DOI
10.21203/rs.3.rs-489056/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Novel Immune-Related Gene Signature for Risk Stratification and Prognosis of Survival in Estrogen Receptor (ER) or Progesterone Receptor (PR) Positive and Human Epidermal Growth Factor Receptor 2 (HER2) Negative Breast CancerDOI 10.21203/rs.3.rs-489056/v1
Select a neighboring publication to make it the new centre.